South Korean chipmaker bats US FDA approval of its non-invasive glucose monitoring device
(Credit: Dongwoon Anatech) South Korean fabless manufacturer Dongwoon Anatech is seeking the approval of both the US and Korean Food and Drug Administration for the commercial rollout of its saliva-based glucose monitoring device after completing its first clinical trial in December. WHAT IT DOES The sugar monitoring device called D-SaLife, a product of six years of research and development, makes use of microcurrent control technology in determining the glucose level present in a person’s saliva sample. The meter colour codes the result of the reading which is also recorded through a mobi...
Source: mobihealthnews.com